Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Using only hyperandrogenism to diagnose PCOS can lead to overdiagnosis.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Many people diagnosed with androgenic alopecia might actually have hidden scarring or inflammation.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

Dutasteride 0.5mg improves hair growth in 78% of people with hair loss, but may cause sexual problems in some.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

In Pakistan, men with more severe hair loss often have a higher BMI.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.